— Know what they know.
Not Investment Advice
Also trades as: 0R0H.L (LSE) · $vol 8M · TMO.NE (NEO) · $vol 0M · TN8.DE (XETRA) · $vol 0M

TMO NYSE

Thermo Fisher Scientific Inc.
1W: +6.3% 1M: +10.6% 3M: +19.1% YTD: -5.6% 1Y: +18.0% 3Y: +4.7% 5Y: +8.6%
$576.41
+16.88 (+3.02%)
 
Weekly Expected Move ±5.2%
$509 $539 $568 $598 $628
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Buy · Power 76 · $214.2B mcap · 371M float · 0.637% daily turnover · Short 40% of daily vol
Smart Money Score
Moderate 50
Insider
Congress3 trades
ETF Holdings
Key Statistics
Market Cap$214.2B
52W Range435.27-643.99
Volume2,535,098
Avg Volume2,362,109
Beta0.87
Dividend$1.80
Analyst Ratings
36 Buy 6 Hold 0 Sell
Consensus Buy
Company Info
CEOMarc N. Casper
Employees125,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1980-03-17
168 Third Avenue
Waltham, MA 02451
US
781 622 1000
About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Pettiti Gianluca S-Sale 400 $565.00 2026-07-27
JOHNSON JENNIFER M A-Award 61 2026-06-27
SPERLING SCOTT M A-Award 83 2026-06-27
Keith R. Alexandra A-Award 61 2026-06-27
WEISLER DION J A-Award 73 2026-06-27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms